Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 40.00
+0.15 (0.38%)
Jul 30, 2026, 12:23 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.57 billion as of July 29, 2026. Its market cap has decreased by -9.74% in one year.
Market Cap
3.57B
Enterprise Value
2.72B
Revenue
825.25M
Ranking
n/a
PE Ratio
13.28
Stock Price
40.00
ChartMarket Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.57B, an increase of 1.38%. That is a compound annual growth rate of 0.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.57B | -6.89% |
| Dec 31, 2025 | 3.84B | -12.06% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 5.66B |
| Pacific Hospital Supply | 5.48B |
| Formosa Optical Technology | 5.31B |
| St.Shine Optical | 4.59B |
| Bionime | 4.51B |
| SciVision Biotech | 3.67B |
| ICARES Medicus | 3.27B |
| Nang Kuang Pharmaceutical | 3.20B |